Join
Live feed
·
PRReleasevia Quantisnow
Galectin Therapeutics Inc. logo

Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet

ByQuantisnow·Wall Street's wire, on your screen.
GALT· Galectin Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GALT (Galectin Therapeutics Inc.) and more on Quantisnow.